The Science
Aging leaves a legible signature in the blood.
Aging is not the accumulation of birthdays. It is the accumulation of physiological drift, a slow and quantifiable shift in the way the body regulates inflammation, metabolism, hormonal balance, cellular renewal and organ function. It shows up in the blood before it shows up in symptoms, and before it shows up in disease.
Three generations
Where the aging clock field stands today.
Gen 1
Chronological age prediction
The first generation of aging clocks was trained to predict chronological age from biological data. The residual was interpreted as age acceleration. Foundational, but a model that perfectly predicts chronological age is by definition useless. Insufficient as a clinical or actuarial instrument.
Gen 2
Mortality and healthspan anchored
Second generation clocks reframed the target: predict mortality risk and disease onset. Biological age is reported as the chronological age at which mortality risk would be typical in the reference population. Hazard ratios of 1.4 to 1.5 per SD of age acceleration, replicated across hundreds of thousands of individuals. Current commercial and clinical state of the art.
Gen 3
Pace of aging
Third generation clocks ask a different question: how fast is this person aging right now. Trained on longitudinal data, they produce a rate rather than a state, especially relevant for evaluating interventions where biological age may not shift in three months but pace of aging measurably slows.
Where Alpha sits
At the intersection of the second and third generations.
Alpha's architecture produces both a mortality anchored biological age estimate (in the Gen 2 tradition) and a pace of aging measurement (in the Gen 3 tradition), from a single blood biomarker input, through a unified deep learning model. The two outputs are internally consistent by construction. To our knowledge, Alpha is the first architecture that unifies these lineages into a single deployable intelligence platform.